Pharmacokinetics and Pharmacodynamics Practice Questions

Q: Which of the following drugs is not metabolized by the liver?

Oxazepam. **Explanation:** The metabolism of Benzodiazepines (BZDs) primarily occurs via two phases in the liver: **Phase I (Oxidation)** by Cytochrome P450 enzymes and **Phase II (Conjugation)** with glucuronic acid. **Why Oxazepam is the correct answer:** Most BZDs undergo Phase I oxidation to form active metabolites, which significantly prolongs their duration of action. However, a specific group of BZDs—**Oxazepam, Temazepam, and Lorazepam (mnemonic: OTL)**—bypass Phase I oxidation entirely. They undergo direct **Phase II glucuronidation** to form inactive, water-soluble metabolites that are excreted by the kidneys. Because they do not rely on the CYP450 system, they are the drugs of choice in patients with **liver failure** or the **elderly**, where oxidative capacity is diminished. **Analysis of Incorrect Options:** * **Diazepam:** A long-acting BZD that undergoes extensive Phase I metabolism to form active metabolites like desmethyldiazepam (nordiazepam), giving it a very long half-life. * **Flunitrazepam & Nitrazepam:** These are nitro-benzodiazepines. They undergo Phase I reduction and acetylation in the liver before excretion. **NEET-PG High-Yield Pearls:** 1. **OTL (Oxazepam, Temazepam, Lorazepam):** "Outside The Liver" (mnemonic for bypassing Phase I). Safe in cirrhosis and elderly patients. 2. **Active Metabolites:** Diazepam and Chlordiazepoxide have the longest-acting active metabolites. 3. **Enzyme Inhibition:** Drugs like Cimetidine or Erythromycin inhibit CYP450 and can increase the toxicity of Diazepam, but they do **not** affect the clearance of Oxazepam or Lorazepam.

Q: Which of the following is a pro-drug?

Enalapril. **Explanation:** **Enalapril** is the correct answer because it is a **prodrug**, an inactive compound that must undergo metabolic conversion (usually in the liver) to become pharmacologically active. Enalapril is converted by hepatic esterases into its active form, **Enalaprilat**, which then acts as an ACE inhibitor. Most ACE inhibitors are prodrugs (e.g., Ramipril, Perindopril) to improve oral bioavailability, with two notable exceptions: **Lisinopril and Captopril**, which are active as administered. **Analysis of Incorrect Options:** * **Clonidine:** An alpha-2 adrenergic agonist used in hypertension. It is active in its parent form and does not require metabolic activation. * **Streptomycin:** An aminoglycoside antibiotic that acts directly by binding to the 30S ribosomal subunit. It is not a prodrug. * **Morphine:** A potent opioid analgesic that is active itself. While it has active metabolites (e.g., Morphine-6-glucuronide), the parent drug is pharmacologically active upon administration. **High-Yield Clinical Pearls for NEET-PG:** * **ACE Inhibitor Exceptions:** Remember the mnemonic **"CL"** (Captopril and Lisinopril) for ACE inhibitors that are **NOT** prodrugs. * **Common Prodrugs:** High-yield examples include Levodopa (to Dopamine), Cyclophosphamide (to Phosphoramide mustard), Clopidogrel, and Valacyclovir. * **Advantages of Prodrugs:** They are designed to improve absorption (bioavailability), decrease toxicity, or prolong the duration of action. * **Active Metabolites:** Do not confuse prodrugs with drugs that have active metabolites (e.g., Diazepam to Oxazepam). A prodrug *must* be inactive initially.

Q: If the clearance of a drug equals its renal plasma flow, what does it imply about the drug's handling by the kidneys?

The drug is actively secreted into the renal tubules.. The concept of **Renal Clearance ($CL_r$)** is a measure of the volume of plasma cleared of a drug per unit of time [3]. To understand how a drug is handled by the kidney, we compare its clearance to the **Glomerular Filtration Rate (GFR)** and **Renal Plasma Flow (RPF)**. 1. **Why Option B is Correct:** Normal GFR is approximately **125 mL/min**, while Renal Plasma Flow (RPF) is approximately **650 mL/min**. If a drug's clearance equals the RPF, it means that *all* the plasma passing through the kidney is being stripped of the drug in a single pass [2]. Since only 20% of plasma is filtered at the glomerulus, the remaining 80% must be cleared via **active tubular secretion** in the proximal tubules to reach a clearance value equal to the RPF [1]. 2. **Why Other Options are Incorrect:** * **Option A:** If a drug is actively reabsorbed (like glucose or certain electrolytes), its clearance will be significantly **lower than the GFR** ($<125$ mL/min) [1]. * **Option C:** If a drug undergoes only filtration with no secretion or reabsorption (like **Inulin**), its clearance will **equal the GFR** (~125 mL/min) [3]. **High-Yield NEET-PG Pearls:** * **Inulin Clearance:** The gold standard for measuring GFR ($CL = GFR$) [3]. * **Creatinine Clearance:** Slightly overestimates GFR because it undergoes a small amount of tubular secretion. * **Para-aminohippuric acid (PAH):** The classic example of a drug where clearance equals RPF because it is both filtered and completely secreted [2]. * **Formula:** $Excretion = (Filtration + Secretion) - Reabsorption$. If Clearance > GFR, secretion is occurring [1].

Q: The pharmacokinetic properties of a new antihistamine are being studied in normal volunteers during phase I clinical trials. The clearance and half-life of the drug are determined to be 4.0 L/hour and 10 hours, respectively. Which of the following values is the approximate volume of distribution for this drug?

60 L. ### Explanation **1. Why the Correct Answer is Right** The volume of distribution ($V_d$) is a theoretical volume that relates the amount of drug in the body to its concentration in the plasma. To solve this, we use the fundamental pharmacokinetic relationship between **Clearance ($CL$)**, **Half-life ($t_{1/2}$)**, and **Volume of Distribution ($V_d$)**: $$t_{1/2} = \frac{0.693 \times V_d}{CL}$$ Rearranging the formula to solve for $V_d$: $$V_d = \frac{t_{1/2} \times CL}{0.693}$$ **Calculation:** * $CL = 4.0 \text{ L/hr}$ * $t_{1/2} = 10 \text{ hours}$ * $V_d = \frac{10 \times 4.0}{0.693} \approx \frac{40}{0.7} \approx 57.14 \text{ L}$ The value **60 L** (Option D) is the closest approximation. **2. Why the Incorrect Options are Wrong** * **Option A (0.06 L):** This value is physiologically impossible for an adult and likely results from a decimal error in calculation. * **Option B (14 L):** This represents the extracellular fluid volume. A drug with this $V_d$ would be restricted to plasma and interstitial fluid. * **Option C (45 L):** This represents total body water (TBW). While closer, it does not match the mathematical result derived from the provided clearance and half-life. **3. Clinical Pearls & High-Yield Facts for NEET-PG** * **$V_d$ Interpretation:** If $V_d$ is low (approx. 3–5 L), the drug is confined to the vascular compartment (e.g., Warfarin). If $V_d$ is high (>42 L), the drug is sequestered in tissues (e.g., Digoxin, Chloroquine). * **Loading Dose:** $V_d$ is the primary determinant of the **Loading Dose** ($LD = V_d \times C_{ss}$). * **Clearance:** $CL$ is the primary determinant of the **Maintenance Dose**. * **Half-life:** It takes approximately **4 to 5 half-lives** to reach steady-state concentration ($C_{ss}$) and the same amount of time to eliminate the drug from the body after stopping.

Q: Zero order kinetics is followed by all of the following drugs EXCEPT:

Barbiturates. ### Explanation The core concept here is the difference between **First-order** and **Zero-order kinetics**. **1. Why Barbiturates is the Correct Answer:** Most drugs follow **First-order kinetics**, where a constant *fraction* of the drug is eliminated per unit time (rate depends on plasma concentration). **Barbiturates** (at therapeutic doses) follow first-order kinetics. Therefore, they are the "exception" in this list of drugs known for following zero-order kinetics. **2. Understanding Zero-Order Kinetics (The Incorrect Options):** In **Zero-order kinetics**, a constant *amount* of drug is eliminated per unit time, regardless of the plasma concentration. This usually occurs because the elimination enzymes become saturated. * **Alcohol (Ethanol):** Follows zero-order kinetics at almost all social and clinical concentrations. * **Phenytoin & Theophylline:** These follow "Capacity-limited" or **Michaelis-Menten kinetics**. At low doses, they follow first-order, but at therapeutic or high doses, the metabolic enzymes saturate, shifting them to zero-order kinetics. This makes their plasma levels rise disproportionately with small dose increases, leading to toxicity. **3. High-Yield Clinical Pearls for NEET-PG:** To remember drugs following Zero-order kinetics, use the mnemonic **"WATT P"**: * **W**arfarin (at very high doses) * **A**lcohol / **A**spirin (at high doses) * **T**heophylline * **T**olbutamide * **P**henytoin **Key Distinction:** * **First-order:** Half-life ($t_{1/2}$) is **constant**. * **Zero-order:** Half-life ($t_{1/2}$) is **variable** (increases with dose/concentration). This is why drugs like Phenytoin require therapeutic drug monitoring (TDM).

Question 1

Which of the following drugs is not metabolized by the liver?

Accepted Answer

Oxazepam

Answer

Flunitrazepam

Answer

Diazepam

Answer

Nitrazepam

Question 2

Which of the following characteristics best describes phenytoin pharmacokinetics?

Accepted Answer

Capacity limited metabolism that saturates at higher therapeutic concentration ranges

Answer

High first pass metabolism

Answer

Nonsaturation kinetics of metabolism

Answer

Extrahepatic metabolism

Question 3

Which of the following is a pro-drug?

Accepted Answer

Enalapril

Answer

Clonidine

Answer

Streptomycin

Answer

Morphine

Question 4

Gentamicin has a half-life of 2-3 hours in plasma, but it accumulates in the kidney, prolonging its half-life to 53 hours. What is this prolonged half-life called?

Accepted Answer

Terminal half-life

Answer

Secondary half-life

Answer

Zero order half-life

Answer

First order half-life

Question 5

If the clearance of a drug equals its renal plasma flow, what does it imply about the drug's handling by the kidneys?

Accepted Answer

The drug is actively secreted into the renal tubules.

Answer

The drug is actively reabsorbed in the renal tubules.

Answer

The drug undergoes neither significant secretion nor reabsorption in the renal tubules.

Answer

None of the above.

Question 6

Which of the following best defines bioavailability?

Accepted Answer

The proportion of an administered drug that reaches the systemic circulation unchanged.

Answer

The volume of plasma completely cleared of a specific compound per unit time, serving as a measure of kidney function.

Answer

Both A and B.

Answer

Neither A nor B.

Question 7

Time-dependent killing and prolonged post-antibiotic effect are characteristic of which class of antibiotics?

Accepted Answer

Beta-lactams

Answer

Fluoroquinolones

Answer

Clindamycin

Answer

Erythromycin

Question 8

Which of the following is NOT an example of nonlinear kinetics?

Accepted Answer

Metabolism of diazepam

Answer

Metabolism of phenytoin

Answer

Biliary secretion of bromosulfthalein (BSP)

Answer

Glomerular filtration of naproxen

Question 9

The pharmacokinetic properties of a new antihistamine are being studied in normal volunteers during phase I clinical trials. The clearance and half-life of the drug are determined to be 4.0 L/hour and 10 hours, respectively. Which of the following values is the approximate volume of distribution for this drug?

Accepted Answer

60 L

Answer

0.06 L

Answer

14 L

Answer

45 L

Question 10

Zero order kinetics is followed by all of the following drugs EXCEPT:

Accepted Answer

Barbiturates

Answer

Phenytoin

Answer

Alcohol

Answer

Theophylline

Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics — MCQs

On this page

Practice by Chapter

Want unlimited practice?